We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
O and W
For listed stocks, nobody else is 'producing' other than NCYT but happy to be corrected by others on that.
No sure they'll 'suffer', demand is far greater than capacity to supply for numerous providers.
Thankyou dogdays, we all appreciate that.
Which producer of PCR tests is most likely to suffer from the GeneDrive96 PCR test in the lab? Ncyt's? Who else?
@Flyingmachine - I have messaged Sam Blanchard at the DM with Twitter link.
Thanks LP, RNS not cheap then
DM - £1,500 cost per RNS.
Check Novacyt RNS. sold into many countries. Believe one statement was 90 different geographies sold into.
Did NCYT only get orders from France... No other countries?
What are thoughts on whether it is better for GDR to release news of several orders in one RNS or one by one as and when orders come in? Does it cost much to release an RNS?
The more tweets I see come out the more confident I am of some excellent news next week...… its almost like they are trying to give us the heads up (in my mind anyway) ;-0
If GDR steels the french market under NCYT nose that will be a very good signal for other markets. GDR just needs a few good sales and this will re-rate to £4.
I wonder if this is hint at a possible deal with the french?
The insurance companies over there have knocked Novacyt back because there test only detects the one gene... just a thought.
On Twitter now
https://twitter.com/genedriveplc?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5Eauthor
'Genedrive 96 SARS-CoV-2 test helps monitor poor sampling. the “RNaseP” signal that tells you there is human DNA in the sample.'
@technick yes that's what I was getting at but you said it better :-) Also comment on Linkedin post clarifies it too:
"The real benefits of such a consistent manufacturing process and removing the need to make up your test components, congratulations everyone"
I think the GDR test reduces the chance of failures outside of sample, so it gives a clear indication that sample was a problem rather than component issues or process issues in the lab
@OaW and what test on the market does that at POC at present?
The GDR test is clearly an advantage/help over current tests if it's able to tell you that the reason for an inconclusive result was that there was insufficient DNA i.e. a poor sample taken at POC. It would wave a red flag backed up with evidence to say 'look, people need to have clearer instructions and be supervised if appropriate' to ensure each test submitted isn't just a waste of time
@scart, that's where I don't see this as a GenedRive advantage. With the high degree of poor swab taking samples, it's of little use to have a better, faster higher throughput, more accurate PCR test in the lab telling you this, if it is still 24 hours or longer after the swab sample was taken.
Folks need to know on the spot, at the POC, if their sample was useless from a test point of view.
Ok, I've sent an email to the DM 'story tips' section to follow up their great article on swab testing issues by taking a look at a new CE Marked PCR test that has buit-in integrated controls that help mitigate and provide better understanding of these current issues.
Is anyone able to email Sam Blanchard, the Daily Mail reporter, with the Linked-In post and suggest he interview David Budd about the USP of Genedrive's CE Marked PCR test?
Would be good if they got this on their Twitter account. Hope someone’s reading this....
@scart - thanks for posting the linkedin ....
I think further issues with current tests in play are proving they were not upto the job, given the virus knowledge curve labs are in...
most producers now are paving the way for the gdr kit... to hit the front and be the choice of the world.
all other kits.... just bin em - roll on the royal warrant for gdr.. Covid 19 Test Kit by appointment etc..
imo.
Imagine how many rubbish sub par tests are out there and have taken place so far...it exactly what I said it like the PPE Scramble a few months ago..the Govs around the world were buying anything which even remotely resembled PPE and most of it was $ hi T. I know people who have had tests... either inconclusive or false negative.. honestly what is the poi t of a test if its not 100%? DB needs to let the market place know our tests are the best out there.
And all the talk of the nose test not being done properly, it's as if the throat swab part of the test is then not relevant
If both parts are important, then it does make me wonder how a saliva test only will be able to have the same level of accuracy
@ghia yeh I think that's what @punter just pointed out, definitely does :-)
@OaW ha sorry, having just read @technick's response I think I was confused by your question... I was clarifying that it's at the lab afterwards that you'll find out if sampling was an error i.e. you won't know at POC to be able to do a quick retest until that device is out.
As @technick said, given the test is a 1-step process for the lab then it's a very high probability that if there is a sampling error then it's at POC.
Scart - Correct me if i'm wrong but that very reason is why the NCYT test has been excluded from use by the French government despite primer being a French company. Bodes well for GDR having these controls in their test by design.